Allied Market Research


Oncology Nutrition Market

Oncology Nutrition Market Size, Share, Competitive Landscape and Trend Analysis Report, by Type : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Cancer involves uncontrollable growth of abnormal cells. These cells are called as tumor cells or malignant cells. The field of medication that deals with the avoidance, treatment, and analysis of cancer is known as oncology. Oncology nutrition is termed as nutrition and diet for a cancer patient either during treatment or after the treatment. Nutrition plays a significant role in several aspects of cancer development and is an important helpful therapy during cancer treatment. Adequate nutrition provision can help cancer patients to maintain weight and slim body composition, offering improved recovery, and better quality of life. Right nutrition for a patient suffering from cancer delivers strength to fight with the illness. The correct food helps the patient endure the distressing effects of cancer and its treatment. Good nutrition also provides more energy and improves the quality of life by dealing with side effects of treatment and helps in speeding the recovery of the patient. Furthermore, it also helps in healing wounds after chemotherapy, radiotherapy, surgery, or other treatment. 

Development of elemental formulas and launch of new products for nutrition of oncology patients, rise in prevalence of cancer, increase in focus on enteral nutrition, surge in demand for nutritional food from the homecare sector are expected to drive the oncology nutrition market in the coming years. Moreover, rise in clinical research on nutritional interventions, and increase in awareness for nutrition of cancer patients are expected to boost the oncology nutrition market during the forecast period. However, tube feeding-related complications and restricted reimbursement associated with its use are the major restraints that can hamper the growth of the market. In addition, rapid product origination and improvement of elemental formulas in the field are expected to provide numerous opportunities for the oncology nutrition market in the coming years.

The oncology nutrition market is segmented based on type of cancer, and region. Based on type of cancer, the market is categorized into head & neck cancer, stomach and gastrointestinal cancers, esophageal cancer, pancreatic cancer, liver cancer, blood cancer, breast cancer, and other cancers. The neck and head segment accounted for an important share of the oncology nutrition market.  Neck and head cancer patients suffer from chronic problems associated to oral nutritional consumption through enteral route for nutrition support. The use of tube nurturing formulas has experienced growth with an increase in the number of cancer cases. The neck and head cancer reports for around 4% of all cancers in the U.S. American Society of Clinical Oncology (ASCO), in 2017, reported that 64,690 people (17,040 women and 47,650 men) developed neck and head cancer in 2017. Based on region, the oncology nutrition market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players operating in the oncology nutrition market include FMC Corporation, Danone, Abbott Laboratories, Aceto, B. Braun Melsungen AG, Baxter International, BioSig Technologies, Fresenius Kabi AG, Global Health Products, Hansen Medical, Hormel Foods, Mead Johnson Nutrition Company, Meiji Holdings, Nestle S.A., and Victus.

  • This report provides a detailed quantitative analysis of the current market trends and market forecast estimations which helps identify the prevailing oncology nutrition market opportunities. 
  • An in-depth market analysis includes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the global market is provided.
  • Region-wise and country-wise oncology nutrition market conditions are comprehensively analyzed in this report.
  • The projections in this report are made by analyzing the current market trends and future market potential in terms of value.
  • nalysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.An extensive a
  • Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global oncology nutrition market.  

Oncology Nutrition Market Report Highlights

Aspects Details
By Type
  • Head & Neck Cancer
  • Stomach & Gastrointestinal Cancers
  • Esophageal Cancer
  • Pancreatic Cancer
  • Liver Cancer
  • Blood Cancer
  • Breast Cancer
  • Lung Cancer
  • Other cancers
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

Danone, Hansen Medical, Abbott Laboratories, Fresenius Kabi AG, Aceto, B. Braun Melsungen AG, FMC Corporation, Global Health Products, Baxter International, BioSig Technologies

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Oncology Nutrition Market

Global Opportunity Analysis and Industry Forecast, 2023-2032